Omar Abdel-Wahab Selected Research

Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell)

1/2019	Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis.
1/2017	High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omar Abdel-Wahab Research Topics

Disease

104	Neoplasms (Cancer) 01/2022 - 01/2004
26	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 04/2010
24	Leukemia 01/2022 - 03/2010
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 11/2013
12	Histiocytosis 01/2021 - 01/2016
10	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 09/2013
7	Melanoma (Melanoma, Malignant) 01/2018 - 08/2004
6	Erdheim-Chester Disease 01/2020 - 10/2016
5	Disease Progression 01/2022 - 03/2013
5	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 06/2013
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2020
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2012
3	Uveal melanoma 01/2022 - 09/2012
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
3	Residual Neoplasm 12/2021 - 02/2013
3	Hypersensitivity (Allergy) 01/2020 - 06/2013
3	Carcinogenesis 11/2019 - 03/2019
3	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 04/2010
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 03/2018 - 01/2016
3	Polycythemia Vera 07/2015 - 10/2010
3	Splenomegaly 03/2015 - 09/2012
2	Anemia 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 12/2018
2	Hairy Cell Leukemia 01/2021 - 10/2015
2	Neuroblastoma 01/2021 - 01/2016
2	Fibrosis (Cirrhosis) 01/2020 - 12/2015
2	Non-Langerhans-Cell Histiocytosis (Histiocytosis, Non Langerhans Cell) 01/2019 - 01/2017
2	Juvenile Myelomonocytic Leukemia 01/2017 - 06/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017 - 10/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2013 - 02/2011
2	Glioma (Gliomas) 02/2012 - 03/2010
2	Thrombocytosis (Thrombocythemia) 10/2010 - 04/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

26	RNA Splicing FactorsIBA 01/2022 - 05/2012
24	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
17	Phosphotransferases (Kinase)IBA 01/2021 - 04/2010
14	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2010
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2014
8	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2005
7	Pharmaceutical PreparationsIBA 01/2021 - 08/2004
7	Histones (Histone)IBA 01/2021 - 01/2012
7	alpha-hydroxyglutarateIBA 03/2014 - 03/2010
6	Biological ProductsIBA 01/2022 - 12/2014
6	VemurafenibIBA 01/2020 - 12/2012
5	Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2016
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2014 - 03/2010
4	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2017
4	ChromatinIBA 01/2022 - 09/2012
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2017
4	CytosineIBA 10/2020 - 10/2012
4	EnzymesIBA 01/2017 - 09/2004
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2014
3	LigandsIBA 11/2021 - 01/2018
3	cobimetinibIBA 01/2020 - 05/2014
3	acetoacetic acid (acetoacetate)IBA 01/2017 - 08/2015
3	CytokinesIBA 12/2015 - 06/2013
2	Amino Acids FDA Link 01/2022 - 01/2020
2	InterferonsIBA 01/2022 - 08/2013
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2021
2	pirtobrutinibIBA 01/2022 - 01/2021
2	CalreticulinIBA 01/2022 - 01/2018
2	venetoclaxIBA 12/2021 - 01/2021
2	RNA Splice SitesIBA 01/2021 - 01/2020
2	Decitabine FDA Link 01/2021 - 05/2015
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 04/2013
2	CholesterolIBA 10/2020 - 02/2013
2	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 01/2018
2	Interleukin-3 (Interleukin 3)IBA 01/2020 - 06/2013
2	Arginine (L-Arginine)FDA Link 12/2019 - 05/2012
2	MethyltransferasesIBA 12/2019 - 01/2018
2	AnthracyclinesIBA 01/2019 - 12/2016
2	Cell-Free Nucleic AcidsIBA 01/2019 - 12/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 05/2014
2	KetonesIBA 01/2017 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 06/2013
2	ruxolitinibIBA 12/2015 - 03/2015
2	Janus Kinase InhibitorsIBA 12/2015 - 03/2015
2	Glutathione (Reduced Glutathione)IBA 09/2004 - 08/2004
2	Melphalan (Alkeran)FDA LinkGeneric 09/2004 - 08/2004
1	Cancer VaccinesIBA 01/2022
1	AlpelisibIBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	IronIBA 01/2022
1	GATA Transcription FactorsIBA 01/2022
1	NucleotidesIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2022
1	Thymidine KinaseIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	InflammasomesIBA 01/2022

Therapy/Procedure

44	Therapeutics 01/2022 - 08/2004
7	Immunotherapy 01/2022 - 01/2004
3	Drug Therapy (Chemotherapy) 12/2016 - 08/2004